Page last updated: 2024-08-17

bromodeoxyuridine and lycopene

bromodeoxyuridine has been researched along with lycopene in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hantz, HL; Martin, KR; Young, LF	1
Barber, JA; Barber, NJ; Martin, FL; Morris, JD; Muir, GH; Pramanik, R; Zhang, X; Zhu, G	1
Fornelli, F; Leone, A; Minervini, F; Verdesca, I; Zacheo, G	1

Trials

1 trial(s) available for bromodeoxyuridine and lycopene

Article	Year
Lycopene inhibits DNA synthesis in primary prostate epithelial cells in vitro and its administration is associated with a reduced prostate-specific antigen velocity in a phase II clinical study. Prostate cancer and prostatic diseases, 2006, Volume: 9, Issue:4 Topics: Aged; Anticarcinogenic Agents; Antimetabolites, Antineoplastic; Biomarkers, Tumor; Bromodeoxyuridine; Carotenoids; Disease Progression; DNA, Neoplasm; Dose-Response Relationship, Drug; Epithelial Cells; Follow-Up Studies; Humans; Lycopene; Male; Prostate; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Regression Analysis; Treatment Outcome	2006

Article

Year

Lycopene inhibits DNA synthesis in primary prostate epithelial cells in vitro and its administration is associated with a reduced prostate-specific antigen velocity in a phase II clinical study.

Prostate cancer and prostatic diseases, 2006, Volume: 9, Issue:4

Topics: Aged; Anticarcinogenic Agents; Antimetabolites, Antineoplastic; Biomarkers, Tumor; Bromodeoxyuridine; Carotenoids; Disease Progression; DNA, Neoplasm; Dose-Response Relationship, Drug; Epithelial Cells; Follow-Up Studies; Humans; Lycopene; Male; Prostate; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Regression Analysis; Treatment Outcome

2006

Other Studies

2 other study(ies) available for bromodeoxyuridine and lycopene

Article	Year
Physiologically attainable concentrations of lycopene induce mitochondrial apoptosis in LNCaP human prostate cancer cells. Experimental biology and medicine (Maywood, N.J.), 2005, Volume: 230, Issue:3 Topics: Anticarcinogenic Agents; Apoptosis; Bromodeoxyuridine; Carotenoids; Cell Proliferation; Cytochrome c Group; Dose-Response Relationship, Drug; Humans; L-Lactate Dehydrogenase; Lycopene; Male; Membrane Potentials; Mitochondria; Prostatic Neoplasms; Tumor Cells, Cultured	2005
The influence of lycopene on the proliferation of human breast cell line (MCF-7). Toxicology in vitro : an international journal published in association with BIBRA, 2007, Volume: 21, Issue:2 Topics: Anticarcinogenic Agents; Breast Neoplasms; Bromodeoxyuridine; Carotenoids; Cell Communication; Cell Line, Tumor; Cell Proliferation; Connexin 43; Female; Gap Junctions; Humans; Immunohistochemistry; Lycopene; RNA, Messenger	2007

Article

Year

Physiologically attainable concentrations of lycopene induce mitochondrial apoptosis in LNCaP human prostate cancer cells.

Experimental biology and medicine (Maywood, N.J.), 2005, Volume: 230, Issue:3

Topics: Anticarcinogenic Agents; Apoptosis; Bromodeoxyuridine; Carotenoids; Cell Proliferation; Cytochrome c Group; Dose-Response Relationship, Drug; Humans; L-Lactate Dehydrogenase; Lycopene; Male; Membrane Potentials; Mitochondria; Prostatic Neoplasms; Tumor Cells, Cultured

2005

The influence of lycopene on the proliferation of human breast cell line (MCF-7).

Toxicology in vitro : an international journal published in association with BIBRA, 2007, Volume: 21, Issue:2

Topics: Anticarcinogenic Agents; Breast Neoplasms; Bromodeoxyuridine; Carotenoids; Cell Communication; Cell Line, Tumor; Cell Proliferation; Connexin 43; Female; Gap Junctions; Humans; Immunohistochemistry; Lycopene; RNA, Messenger

2007